All Insights

Markets

The Anthropic IPO: What It Means for LPs

Anthropic has filed to list on Nasdaq as ANT. For limited partners, the opening bell matters less than the marks, lockups, and in-kind distributions that follow.

Matthew S. · Allocator Desk · November 2026 · 11 min read

For most of the past five years, the only way an institutional LP could own a piece of a frontier AI lab was indirectly: through a venture or growth fund that got an allocation, a crossover vehicle, or a secondary that changed hands at a price nobody wanted to say out loud. That is about to change. Anthropic, the company behind Claude, publicly filed its S-1 on October 26, 2026 and intends to list Class A shares on the Nasdaq Global Select Market under the ticker ANT, with Goldman Sachs and Morgan Stanley leading the deal (Anthropic).

Retail investors will ask whether to buy on day one. LPs have a more interesting set of questions, because many of them already own it, they just do not know how much, at what mark, or when the cash shows up.

The short version: an IPO turns a private mark into a public price, but it does not turn it into DPI. For LPs, the real event is not the opening bell. It is the six to eighteen months after it.

What we actually know (as of November 9, 2026)

Here is the factual base, drawn from the filing and reporting around it. Anything not listed here, including the final price range and share count, had not been disclosed at the time of writing.

| Item | What has been reported | | --- | --- | | Public S-1 filed | October 26, 2026 | | Ticker and venue | ANT, Nasdaq Global Select (Class A) | | Lead banks | Goldman Sachs, Morgan Stanley | | Last private round | $65 billion Series H at a $965 billion valuation | | 2024 revenue | $386 million | | 2025 revenue | $4.58 billion | | 2025 compute and infrastructure costs | $7.33 billion | | Cash and short-term investments (June 30, 2026) | about $131.65 billion | | Q3 2026 revenue | $16.96 billion, up from $11.56 billion in Q2 | | Earliest possible first trade | week of November 16, 2026 |

Sources: the company's announcement, SmartAsset's summary of the S-1 (SmartAsset), Investing.com's analysis of the amended filing (Investing.com), and Yahoo Finance's timeline (Yahoo Finance).

Two numbers deserve a second look. Revenue went from $41 million in 2023 to $4.58 billion in 2025, which is the kind of curve venture decks draw and almost nobody delivers. And compute spending in 2025 was larger than revenue. Both facts are true at once, and the IPO price is essentially the market voting on which one matters more.

The valuation got a haircut before the deal even launched

A month ago, the conversation was about $1.8 trillion to $2 trillion. After a sharp AI selloff, in which Nasdaq-listed companies reportedly lost a combined $2.5 trillion in a single day, some prospective investors were discussing $1.1 trillion to $1.3 trillion (Investing.com).

That is a useful lesson for LPs, and it is free. A private valuation is a negotiated number between a company and the investors willing to write the next check. A public valuation is a number set by everyone, every day, including people who have never met the CEO. The gap between those two can move by hundreds of billions of dollars in a week. Even the low end of the reported range is above the $965 billion Series H, so later-stage holders are still likely to be marked up. But the uplift is smaller than the headlines a month ago implied, and it can still move.

Why an LP should care even without a direct position

1. You may already own it, two layers down

If your portfolio includes venture, growth equity, crossover funds, or AI-focused secondaries vehicles, there is a reasonable chance some of your managers hold Anthropic shares, either directly or through SPVs. The issue is that LP reporting rarely surfaces look-through exposure to a single name. You will find out from a quarterly letter that says "a significant portfolio company completed its IPO," usually after the fact.

The practical step this month: ask your venture and growth managers a plain question. Do you hold Anthropic, directly or through a vehicle, and what is it marked at as of September 30? You are not asking for a trade recommendation. You are asking what your exposure is before the market tells you.

2. The mark changes before the money does

When a holding goes public, managers generally move from model-based fair value to the quoted price, adjusted where appropriate for restrictions such as a lockup. That can produce a large step-up in TVPI in a single quarter. It does not change DPI at all.

Lockups on large IPOs are commonly around 180 days, though the terms for this deal will be set out in the final prospectus and can include staged releases. Until shares are sold or distributed, the gain is on paper and exposed to whatever the stock does next. A fund that shows a 4.0x TVPI on the back of one listed position is a different animal from one that shows 4.0x with half of it already returned.

Treat a post-IPO TVPI jump as a forecast, not a result.

3. Distributions may arrive as stock, not cash

When lockups end, many venture GPs distribute shares in kind rather than selling them. That means your custodian receives ANT shares, and your team has to decide whether to hold or sell. Three things to check in advance:

• **Who decides.** Does your policy allow staff to sell distributed shares immediately, or does it need sign-off? A slow approval chain on a volatile stock is an expensive habit.
• **How the distribution is valued.** LPAs vary on whether in-kind distributions are valued at the closing price on the distribution date, an average over several days, or something else. That figure drives carry calculations and your own reported DPI.
• **Whether the GP sells first.** Some managers sell their carried interest shares on the same day the LPs receive theirs. That is often allowed. It is worth knowing.

4. The denominator effect can run the other way

Usually LPs worry that a falling public market makes private allocations look too large. A big private-to-public markup can do the reverse: your private book jumps in value while the rest of the portfolio stands still, pushing you over target in venture without you committing a single new dollar. That can quietly shrink next year's pacing budget for new commitments. Run the scenario now, at the low and high end of the reported valuation range, so you are not surprised in the Q4 board book.

5. Concentration risk hides inside "diversified" funds

A venture fund with forty companies can still have half its NAV in one name after a listing like this. If you hold several funds that all participated in Anthropic rounds, your combined single-name exposure could be meaningfully larger than any individual fund report suggests. This is a look-through problem, and spreadsheets are not good at it.

What the S-1 tells you about the AI theme, not just the stock

Even LPs with zero exposure should read the filing, or at least a good summary of it, because it is the most detailed public look yet at the economics of a frontier AI lab. A few points that carry over into private diligence:

• **Compute is the cost of goods sold, and it is huge.** Reporting on the filing describes roughly half a trillion dollars in noncancelable compute commitments over the next decade ([Finviz](https://finviz.com/news/415079/anthropic-s-1-record-growth-but-is-the-ipo-a-buy)). If you back infrastructure, data center, or power managers, this is the demand side of their underwriting.
• **Growth is decelerating from extraordinary to merely very fast.** Sequential revenue growth of about 47% in Q3 followed 144% in Q2. Private AI companies pitching your managers on comparable multiples should be held to that trajectory, not to the peak quarter.
• **The cash pile changes the competitive math.** Roughly $131.65 billion of cash and short-term investments at mid-year means the company can outspend most private competitors for years. That matters for any venture manager pitching an application-layer startup that depends on not being crushed by the lab it builds on.

What happens to secondaries pricing

Secondary buyers have spent the last few years pricing late-stage AI positions against private round valuations. A public price removes the guesswork for Anthropic itself, and it gives buyers a reference point for every other AI company still private. If the stock trades well, sellers of AI-heavy portfolios will argue for tighter discounts. If it trades poorly, the opposite. Either way, expect the conversation to change quickly, and expect GP-led continuation vehicles holding AI names to cite the trading price in their fairness opinions.

A fun detail: the company is a public benefit corporation

Anthropic, PBC is organized as a public benefit corporation, which means its directors are required to balance shareholder returns with a stated public benefit. For most LPs this is a footnote. For endowments and foundations with mission-alignment policies, it is an interesting test case of how a governance structure designed around a purpose holds up once quarterly earnings calls begin. The S-1's risk factors are worth reading for exactly this reason.

A checklist for this week

1. Ask venture, growth, and crossover managers whether they hold Anthropic and at what September 30 mark. 2. Estimate look-through exposure across all funds, not fund by fund. 3. Confirm your policy for handling in-kind distributions, including who can sell and how quickly. 4. Re-run pacing at a low and high valuation scenario so the Q4 denominator does not surprise anyone. 5. Note, for each fund, whether the gain is TVPI or DPI. Report them separately to your committee. 6. Keep a dated record of what each manager told you. When distributions arrive, you will want to compare.

The bottom line

An Anthropic listing is a genuine milestone for private markets: it is the clearest proof yet that a venture-backed AI lab can reach public-market scale. For LPs, though, the excitement should be measured. A step-up in marks is welcome, but it is not cash, it can reverse, and it can distort pacing and concentration in ways that only show up when you look across funds rather than at them one at a time.

The listing tells you what the company is worth. Your managers' decisions over the next year tell you what it is worth to you.

*This article is for information only and is not investment advice. Figures reflect public filings and reporting available on November 9, 2026, and may change as the offering proceeds.*

Frequently asked questions

When will Anthropic start trading? No date has been confirmed. Under SEC timing rules, the earliest possible first trade is the week of November 16, 2026, with reports pointing to the days just before Thanksgiving.

What ticker will Anthropic use? The company intends to list Class A common stock on the Nasdaq Global Select Market under the symbol ANT.

Does an IPO mean LPs get paid right away? Usually not. Existing holders are typically subject to a lockup, and venture managers often distribute shares in kind after it ends. Expect TVPI to move first and DPI later.

How will my venture fund mark its Anthropic position after the IPO? Most managers move to the quoted market price, sometimes with a discount for lockup restrictions. Ask each manager how they will apply it, since practices differ.

Should LPs buy ANT shares directly in the IPO? That is a portfolio decision, not a default. Many LPs will already have indirect exposure through funds, so measure that first before adding a direct position.

Topics

• Anthropic
• IPO
• Venture Capital
• DPI
• Distributions
• AI